Related Experiment Video
Updated: Mar 8, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis
Hailin Pang1, Ningqiang Ma1, Mi Jiao1
1Department of Oncology, Tangdu Hospital, the Fourth Military Medical UniversityXian, ShaanxiP.R. China.
Abstract:
The bone is among the most common sites of metastasis in patients with lung cancer. Over 30%-40% of lung cancers can develop bone metastasis, and no effective therapeutic methods exist in clinic cases. Wnt/β-catenin signaling and Dickkopf1 (DKK1) play important roles in the progression of lung cancer, which preferentially metastasizes to the skeleton. However, the role of DKK1 in osteotropism of small cell lung cancer (SCLC) remains to be elucidated. This study aimed to define the role of DKK1 in SCLC bone metastasis and investigate the underlying mechanisms. Our results demonstrated that the expression level of DKK1 was dramatically higher in bone metastatic SCLC cells (SBC-5 cell line) compared with that in cells without bone metastatic ability (SBC-3 cell line). Therefore, we hypothesized that DKK1 was involved in the bone metastasis of SCLC. We then suppressed the DKK1 expression in SBC-5 cells by RNAi and found that downregulation of DKK1 can inhibit cell proliferation, colony formation, cell migration, and invasion, but increase the apoptosis rate. Downregulation of DKK1 did not affect the cell cycle progression of SBC-5 cells in vitro. In vivo, downregulated DKK1 in SBC-5 cells resulted in attenuated bone metastasis. These results indicated that DKK1 may be an important regulator in bone metastases of SCLC, and targeting DKK1 may be an effective method to prevent and treat skeleton metastases in SCLC cases.
Insights
Dickkopf1 (DKK1) drives small cell lung cancer (SCLC) bone metastasis by promoting cell growth and invasion. Inhibiting DKK1 significantly reduced SCLC bone metastasis, suggesting DKK1 as a therapeutic target for SCLC skeletal complications.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Bone metastasis is common in lung cancer, with limited therapeutic options.
- Wnt/β-catenin signaling and Dickkopf1 (DKK1) are implicated in lung cancer progression and skeletal metastasis.
- The specific role of DKK1 in small cell lung cancer (SCLC) bone metastasis requires further investigation.
Purpose of the Study:
- To elucidate the role of DKK1 in the bone metastasis of SCLC.
- To investigate the underlying mechanisms by which DKK1 influences SCLC osteotropism.
Main Methods:
- Compared DKK1 expression in SCLC cell lines with and without bone metastatic ability.
- Utilized RNA interference (RNAi) to suppress DKK1 expression in SCLC cells.
- Assessed the effects of DKK1 downregulation on cell proliferation, apoptosis, migration, invasion, and colony formation in vitro.
- Evaluated the impact of DKK1 downregulation on SCLC bone metastasis in vivo.
Main Results:
- DKK1 expression was significantly higher in bone metastatic SCLC cells (SBC-5) compared to non-metastatic cells (SBC-3).
- Downregulation of DKK1 inhibited SCLC cell proliferation, migration, invasion, and colony formation, while increasing apoptosis.
- DKK1 suppression did not alter cell cycle progression in vitro.
- Reduced DKK1 levels attenuated SCLC bone metastasis in vivo.
Conclusions:
- DKK1 plays a crucial role in regulating SCLC bone metastasis.
- Targeting DKK1 presents a potential therapeutic strategy for preventing and treating skeletal metastases in SCLC.
